Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Icaritin with autophagy/mitophagy inhibitors synergistically enhances anticancer efficacy and apoptotic effects through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma
Piao Luo, Yehai An, Jingqian He, et al.
Cancer Letters (2024) Vol. 587, pp. 216621-216621
Closed Access | Times Cited: 16
Advancements in the Biotransformation and Biosynthesis of the Primary Active Flavonoids Derived from Epimedium
Xiaoling Zhang, Bingling Tang, Sijie Wen, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7173-7173
Open Access | Times Cited: 21
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells
Xiangyang Zhou, Di Wu, Tian Mi, et al.
Chemico-Biological Interactions (2024) Vol. 392, pp. 110926-110926
Closed Access | Times Cited: 7
Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges
Kexin Li, Kunmin Xiao, Shijie Zhu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Yi Lu, Yue Gao, Huan Yang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective
Yufang Liu, Han Yang, Jie Xiong, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113991-113991
Open Access | Times Cited: 27
Icaritin: A phytomolecule with enormous pharmacological values
Nguyen Thi Huong, Ninh The Son
Phytochemistry (2023) Vol. 213, pp. 113772-113772
Closed Access | Times Cited: 17
Icariin mediates autophagy and apoptosis of hepatocellular carcinoma cells induced by the β-catenin signaling pathway through lncRNA LOXL1-AS1
Sicheng Gao, Wanyi Zhang, Jinhua Dai, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Advances in Pharmacological Research on Icaritin: A Comprehensive Review
Ran Guo, Zhiping Yan, Rui Wang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-25
Closed Access
Antineoplastic effects of icaritin: molecular mechanisms and applications
Piao Luo, Liyang Zhang, Guangqing Cheng, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 2
Open Access
Epimedium Linn: A Comprehensive Review of Phytochemistry, Pharmacology, Clinical Applications and Quality Control
X. Q. Chen, Shixing Li, Teng Ge, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 8
Closed Access | Times Cited: 4
Icariin as a potential anticancer agent: a review of its biological effects on various cancers
Fang-Yuan Liu, Dan‐Ni Ding, Yun-Rui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Identification of icaritin derivative IC2 as an SCD-1 inhibitor with anti-breast cancer properties through induction of cell apoptosis
Chen Yang, Yi-Yuan Jin, Jie Mei, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature
Wenjie Song, Jian Xu, Ye Nie, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 16, pp. 2847-2855
Open Access | Times Cited: 2
Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability
Weiping Wang, Jiaqi Fan, Fengxiao Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116646-116646
Closed Access | Times Cited: 2
Nucleolin recognizing silica nanoparticles inhibit cell proliferation by activating the Bax/Bcl-2/caspase-3 signalling pathway to induce apoptosis in liver cancer
Liangliang Xiang, Yun Li, Xinyu Gu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy
Shuchen Chen, He Duan, Gongping Sun
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114963-114963
Open Access | Times Cited: 5
The Synergy of Gene Targeting Drug Icaritin Soft Capsule with Immunomodulator and TACE Brings New Hope for Drug Combination in Patients with Advanced Liver Cancer: A Case Report and Literature Review
Xiaoxia Tang, Y. Zhang, Xinyu Dong, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 707-717
Open Access | Times Cited: 5
An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma
Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 10, pp. 2697-2709
Closed Access | Times Cited: 5
The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy
Jiajia Du, Erlei Zhang, Zhiyong Huang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin
Xiaoduan Sun, Zhenzhen He, Ruilin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Anticancer Activity of Delta-Tocotrienol in Human Hepatocarcinoma: Involvement of Autophagy Induction
Marina Montagnani Marelli, Chiara Macchi, Massimiliano Ruscica, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2654-2654
Open Access | Times Cited: 1
Icaritin Exerts Anti-Cancer Effects through Modulating Pyroptosis and Immune Activities in Hepatocellular Carcinoma
Yuanyuan Jiao, Wenqian Li, Wen Yang, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1917-1917
Open Access | Times Cited: 1
Comprehensive review of the traditional uses and the potential benefits of epimedium folium
Jialu Cui, Lin Lin, Feiran Hao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top